Guggenheim Partners & JPMorgan Chase

Guggenheim Partners: Guggenheim Partners acted as a lead book-running manager, earning fees and demonstrating its capability in executing biotech IPOs. The successful offering supports its investment banking business.

JPMorgan Chase: JPMorgan Chase acted as a lead book-running manager for the IPO, earning underwriting fees and strengthening its position in biotech capital markets. The successful offering reflects positively on its investment banking franchise.

Guggenheim Partners: Guggenheim Securities is acting as a bookrunner for Eric Rock's IPO.

JPMorgan Chase: J.P. Morgan is acting as a joint lead bookrunning manager for Eric Rock's IPO, playing a key role in the offering process.

Guggenheim Partners: Guggenheim Securities is a co-global coordinator and joint bookrunner, involved in the IPO.

JPMorgan Chase: J.P. Morgan is a global coordinator and joint bookrunner, earning fees and strengthening its investment banking position.

Guggenheim Partners: Guggenheim Securities acted as additional bookrunning manager, earning underwriting fees.

JPMorgan Chase: J.P. Morgan acted as joint lead bookrunning manager, earning underwriting fees and enhancing its IPO advisory reputation.

Guggenheim Partners: Guggenheim Securities is a joint lead book-running manager for the offering.

JPMorgan Chase: J.P. Morgan is acting as a joint lead book-running manager for the IPO.

Guggenheim Partners: Guggenheim Partners is a former employer of Rohan Sen, mentioned as background, with no direct impact.

JPMorgan Chase: JPMorgan Chase lost a managing director to Citi in July, part of the broader hiring trend, but remains a major competitor.